Global Near Patient Care Diagnostic Market Growth (Status and Outlook) 2026-2032
Description
The global Near Patient Care Diagnostic market size is predicted to grow from US$ 22080 million in 2025 to US$ 37500 million in 2032; it is expected to grow at a CAGR of 8.0% from 2026 to 2032.
Near patient care diagnostics refer to medical diagnostic procedures that are performed at or near the location of patient care, rather than in centralized laboratories. This approach allows for faster, more immediate results, enabling healthcare providers to make quicker decisions regarding diagnosis and treatment. Near patient care diagnostics typically include point-of-care testing (POCT) devices and systems that are designed for use in various healthcare settings, such as hospitals, clinics, physician offices, or even in the home. Common examples include blood glucose meters, pregnancy tests, and portable imaging devices. These diagnostics provide convenience, reduce patient wait times, and improve clinical outcomes by facilitating timely interventions.
United States market for Near Patient Care Diagnostic is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Near Patient Care Diagnostic is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Near Patient Care Diagnostic is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Near Patient Care Diagnostic players cover Roche, Abbott, LifeScan, Siemens Healthineers, Danaher, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Near Patient Care Diagnostic Industry Forecast” looks at past sales and reviews total world Near Patient Care Diagnostic sales in 2025, providing a comprehensive analysis by region and market sector of projected Near Patient Care Diagnostic sales for 2026 through 2032. With Near Patient Care Diagnostic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Near Patient Care Diagnostic industry.
This Insight Report provides a comprehensive analysis of the global Near Patient Care Diagnostic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Near Patient Care Diagnostic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Near Patient Care Diagnostic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Near Patient Care Diagnostic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Near Patient Care Diagnostic.
This report presents a comprehensive overview, market shares, and growth opportunities of Near Patient Care Diagnostic market by product type, application, key players and key regions and countries.
Segmentation by Type:
Blood Glucose Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Pregnancy and Fertility Testing
Blood Gas/Electrolytes Testing
Urinalysis Testing
Other
Segmentation by Application:
Hospital & Clinic
Laboratory
Household
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche
Abbott
LifeScan
Siemens Healthineers
Danaher
Ascensia
BioMerieux
ARKRAY
Bio-Rad Laboratories
Nova Biomedical
QuidelOrtho
Accriva
OraSure Technologies
Helena Laboratories
Phamatech
Chembio Diagnostics
Trinity Biotech
Wuhan Easy Diagnosis
Intec PRODUCT
Sinocare
Wondfo
Getein Biotech
Please note: The report will take approximately 2 business days to prepare and deliver.
Near patient care diagnostics refer to medical diagnostic procedures that are performed at or near the location of patient care, rather than in centralized laboratories. This approach allows for faster, more immediate results, enabling healthcare providers to make quicker decisions regarding diagnosis and treatment. Near patient care diagnostics typically include point-of-care testing (POCT) devices and systems that are designed for use in various healthcare settings, such as hospitals, clinics, physician offices, or even in the home. Common examples include blood glucose meters, pregnancy tests, and portable imaging devices. These diagnostics provide convenience, reduce patient wait times, and improve clinical outcomes by facilitating timely interventions.
United States market for Near Patient Care Diagnostic is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Near Patient Care Diagnostic is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Near Patient Care Diagnostic is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Near Patient Care Diagnostic players cover Roche, Abbott, LifeScan, Siemens Healthineers, Danaher, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Near Patient Care Diagnostic Industry Forecast” looks at past sales and reviews total world Near Patient Care Diagnostic sales in 2025, providing a comprehensive analysis by region and market sector of projected Near Patient Care Diagnostic sales for 2026 through 2032. With Near Patient Care Diagnostic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Near Patient Care Diagnostic industry.
This Insight Report provides a comprehensive analysis of the global Near Patient Care Diagnostic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Near Patient Care Diagnostic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Near Patient Care Diagnostic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Near Patient Care Diagnostic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Near Patient Care Diagnostic.
This report presents a comprehensive overview, market shares, and growth opportunities of Near Patient Care Diagnostic market by product type, application, key players and key regions and countries.
Segmentation by Type:
Blood Glucose Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Pregnancy and Fertility Testing
Blood Gas/Electrolytes Testing
Urinalysis Testing
Other
Segmentation by Application:
Hospital & Clinic
Laboratory
Household
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche
Abbott
LifeScan
Siemens Healthineers
Danaher
Ascensia
BioMerieux
ARKRAY
Bio-Rad Laboratories
Nova Biomedical
QuidelOrtho
Accriva
OraSure Technologies
Helena Laboratories
Phamatech
Chembio Diagnostics
Trinity Biotech
Wuhan Easy Diagnosis
Intec PRODUCT
Sinocare
Wondfo
Getein Biotech
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
160 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Near Patient Care Diagnostic Market Size by Player
- 4 Near Patient Care Diagnostic by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Near Patient Care Diagnostic Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
